免疫組織化學市場報告：2031 年趨勢、預測與競爭分析

全球免疫組織化學市場在醫院和診斷實驗室、學術和研究機構市場前景光明。預計到 2031 年，全球免疫組織化學市場規模將達到 42 億美元，2025 年至 2031 年的複合年成長率為 5.4%。該市場的主要驅動力是醫療保健專業人員擴大採用數位病理學、慢性病患病率上升以及已開發國家老年人口的快速成長。

• Lucintel 表示，從應用角度來看，由於慢性病盛行率不斷上升，診斷應用預計將在預測期內實現最高成長。
• 根據最終用途行業，醫院和診斷實驗室預計將仍然是最大的細分市場，因為醫院擴大將診斷程序轉移到內部。
• 由於各國政府大力投資醫療保健基礎設施和服務，預計亞太地區將在預測期內達到最高成長。

免疫組織化學市場的策略性成長機會

由於技術進步和各種應用需求的不斷成長，免疫組織化學市場呈現多種策略成長機會。這些機會正在塑造 IHC 解決方案的未來。

• 擴大腫瘤學應用：IHC 在癌症診斷和監測中的應用具有巨大的成長潛力。增強的生物標記檢測和新穎的檢測方法可支援更準確的癌症診斷和個人化治療。
• 自動化解決方案的開發：市場為自動化 IHC 染色系統的開發提供了成長機會。自動化是提高實驗室效率和一致性的關鍵投資和發展領域。
• 與數位病理學結合：將 IHC 與數位病理學解決方案相結合可增強資料分析和解釋，創造​​成長機會。這種整合支援更有效率、更準確的診斷和研究。
• 專注於新興市場：透過提供價格合理、適合當地情況的 IHC 解決方案，向新興市場擴張可帶來成長機會。擴展到新興市場可以滿足當地需求並擴大市場範圍。
• 個人化醫療的進步：IHC 在個人化醫療中的應用正在不斷擴大，為開發針對個別患者特徵的檢測方法提供了機會。這一趨勢支持更有針對性和更有效的治療。

這些成長機會凸顯了免疫組織化學市場在腫瘤學、自動化、數位病理學、新興市場和個人化醫療方面的擴張潛力。在這些領域投資將推動創新和市場成長。

免疫組織化學市場促進因素與挑戰

免疫組織化學市場受到各種市場促進因素和挑戰的影響，包括技術進步、經濟因素和監管問題。了解這些因素對於有效駕馭市場至關重要。

推動免疫組織化學市場發展的因素有：

• 技術進步：多重分析和高解析度成像等 IHC 技術的創新正在推動市場成長。這些進步提高了診斷能力並擴大了應用領域。
• 癌症發病率上升：全球癌症發病率上升推動了對用於準確診斷和研究的先進 IHC 解決方案的需求。這些不斷成長的需求正在支持市場擴張。
• 研發成長：不斷增加的研發投入正在推動 IHC 產品和技術的創新。這項投資支持了新檢測方法和解決方案的開發。
• 實驗室自動化：採用自動化 IHC 染色系統提高了實驗室的效率和一致性。自動化支援高吞吐量環境並提高生產力。
• 與數位病理學的整合：IHC 與數位病理學解決方案的整合正在推動資料分析和解釋，提高診斷準確性和研究能力。

免疫組織化學市場面臨的挑戰是：

• 開發成本高：開發先進的 IHC 技術需要大量的研發成本。對於小型企業和新興企業來說，這些高成本可能是一個障礙。
• 法規遵循：滿足 IHC 產品的法規要求可能具有挑戰性，尤其是在某些地區。確保遵守標準對於市場進入和業務營運至關重要。
• 整合複雜性：將新的 IHC 技術整合到現有系統中可能很複雜。確保相容性和無縫操作需要專業知識和周密的規劃。
• 市場競爭：IHC 市場競爭激烈，許多公司提供類似的產品。為了獲得競爭優勢，您需要透過創新和性能來實現差異化。
• 經濟不確定性：經濟波動和不確定性可能會影響 IHC 領域的研究和開發資金。這些經濟因素可能會影響市場成長和投資。

免疫組織化學市場正受到技術進步、癌症盛行率上升和自動化等促進因素的影響，同時面臨高昂的開發成本和法規遵循等挑戰。解決這些市場促進因素和挑戰對於市場的成功和成長至關重要。

目錄

第1章執行摘要

第 2 章全球免疫組織化學市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球免疫組織化學市場趨勢（2019-2024）及預測（2025-2031）
• 全球免疫組織化學市場（按產品）
  • 抗體
  • 試劑
  • 裝置
  • 套件
• 全球免疫組織化學市場（按應用）
  • 診斷用途
  • 研究用途
  • 法醫學應用
• 全球免疫組織化學市場（按最終用途行業分類）
  • 醫院和診斷實驗室
  • 學術和研究機構
  • 其他最終用戶

第4章區域市場趨勢與預測分析（2019-2031）

• 全球免疫組織化學市場（按地區）
• 北美免疫組織化學市場
• 歐洲免疫組織化學市場
• 亞太免疫組織化學市場
• 世界其他地區的免疫組織化學市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球免疫組織化學市場成長機會（按類型）
  • 全球免疫組織化學市場的成長機會（按應用）
  • 全球免疫組織化學市場成長機會（依最終用途產業分類）
  • 全球免疫組織化學市場各區域成長機會
• 全球免疫組織化學市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球免疫組織化學市場產能擴張
  • 全球免疫組織化學市場的企業合併
  • 認證和許可

第7章主要企業簡介

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem
• Histo-Line Laboratories

The future of the global immunohistochemistry market looks promising with opportunities in the hospitals & diagnostic laboratory, and academic & research institute markets. The global immunohistochemistry market is expected to reach an estimated $4.2 billion by 2031 with a CAGR of 5.4% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology by healthcare professionals, the rising prevalence of chronic diseases, and the surge in the geriatric population in developed countries.

• Lucintel forecasts that, within the application category, diagnostic application is expected to witness the highest growth over the forecast period due to the rising incidence of chronic illnesses.
• Within the end use industry category, hospitals & diagnostic laboratories will remain the largest segment due to increasing trend of hospitals conducting diagnostic procedures in-house.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to government is making substantial investments in healthcare infrastructure and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Immunohistochemistry Market

The immunohistochemistry market is experiencing key trends driven by technological advancements and increasing demand for precise diagnostics. These trends are shaping the future of IHC applications and solutions.

• Multiplex IHC Assays: Multiplex assays enable the simultaneous detection of multiple biomarkers in a single sample. This trend enhances diagnostic accuracy and research capabilities by providing comprehensive data in one analysis.
• Automated Staining Systems: The adoption of automated IHC staining systems is increasing efficiency and consistency in laboratories. These systems reduce manual errors and improve reproducibility, making them crucial for high-throughput environments.
• AI and Machine Learning Integration: AI and machine learning are being integrated into IHC image analysis, enhancing the accuracy of biomarker detection and interpretation. These technologies enable more precise and faster data analysis.
• Enhanced Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed and accurate visualization of tissue samples. These techniques support better diagnostics and research outcomes by improving biomarker detection.
• Localized Solutions and Cost Reduction: There is a focus on developing localized IHC solutions to address regional needs and reduce costs. This trend aims to make IHC more accessible and affordable in emerging markets.

These trends are reshaping the immunohistochemistry market by improving diagnostic precision, efficiency, and accessibility. The focus on multiplex assays, automation, AI integration, enhanced imaging, and localized solutions is driving innovation and expanding the applications of IHC technologies.

Recent Developments in the Immunohistochemistry Market

Recent developments in the immunohistochemistry market highlight advancements in technology, automation, and regional growth. These developments are enhancing the capabilities and applications of IHC in diagnostics and research.

• Introduction of Multiplex IHC Assays: New multiplex IHC assays allow for the detection of multiple biomarkers simultaneously, improving diagnostic accuracy and research efficiency. This development supports a more comprehensive analysis of complex diseases.
• Advancement in Automated Staining Systems: Automation in IHC staining systems is increasing, with new systems offering higher throughput and consistency. These advancements reduce manual errors and streamline laboratory workflows.
• Integration of AI in Image Analysis: AI technologies are being incorporated into IHC image analysis, improving the accuracy of biomarker detection and data interpretation. This integration enhances research and diagnostic precision.
• Development of High-Resolution Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed visualization of tissue samples. This development supports better biomarker detection and enhances diagnostic capabilities.
• Expansion of Localized IHC Solutions: There is a growing focus on developing localized IHC solutions to meet regional needs and reduce costs. This expansion is making IHC more accessible in emerging markets.

These developments are advancing the immunohistochemistry market by enhancing diagnostic capabilities, improving efficiency, and expanding accessibility. Innovations in multiplex assays, automation, AI integration, high-resolution imaging, and localized solutions are driving progress in this field.

Strategic Growth Opportunities for Immunohistochemistry Market

The immunohistochemistry market presents several strategic growth opportunities driven by technological advancements and increasing demand across various applications. These opportunities are shaping the future of IHC solutions.

• Expansion in Oncology Applications: There is significant growth potential in using IHC for cancer diagnostics and research. Enhanced biomarker detection and new assays are supporting more accurate cancer diagnoses and personalized treatments.
• Development of Automated Solutions: The market offers growth opportunities in developing automated IHC staining systems. Automation improves laboratory efficiency and consistency, making it a key area for investment and development.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions creates growth opportunities by enhancing data analysis and interpretation. This integration supports more efficient and accurate diagnostics and research.
• Focus on Emerging Markets: Expanding into emerging markets presents growth opportunities by providing affordable and localized IHC solutions. This expansion addresses regional needs and increases market reach.
• Advancements in Personalized Medicine: The application of IHC in personalized medicine is growing, with opportunities to develop assays tailored to individual patient profiles. This trend supports more targeted and effective treatments.

These growth opportunities highlight the potential for expanding the immunohistochemistry market across oncology, automation, digital pathology, emerging markets, and personalized medicine. Capitalizing on these areas will drive innovation and market growth.

Immunohistochemistry Market Driver and Challenges

The immunohistochemistry market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is essential for navigating the market effectively.

The factors responsible for driving the immunohistochemistry market include:

• Technological Advancements: Innovations in IHC technology, such as multiplex assays and high-resolution imaging, are driving market growth. These advancements improve diagnostic capabilities and expand application areas.
• Increasing Cancer Incidence: The rising incidence of cancer globally is driving demand for advanced IHC solutions for accurate diagnostics and research. This growing need supports market expansion.
• Growth in Research and Development: Increased investment in research and development is fostering innovation in IHC products and technologies. This investment drives the development of new assays and solutions.
• Automation in Laboratories: The adoption of automated IHC staining systems is improving efficiency and consistency in laboratories. Automation supports high-throughput environments and enhances productivity.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions is advancing data analysis and interpretation, enhancing diagnostic accuracy and research capabilities.

Challenges in the immunohistochemistry market are:

• High Development Costs: Developing advanced IHC technologies involves significant research and development costs. These high costs can be a barrier for smaller companies and startups.
• Regulatory Compliance: Meeting regulatory requirements for IHC products, particularly in different regions, can be challenging. Ensuring compliance with standards is essential for market entry and operation.
• Complexity of Integration: Integrating new IHC technologies with existing systems can be complex. Ensuring compatibility and seamless operation requires expertise and careful planning.
• Market Competition: The IHC market is competitive, with numerous players offering similar products. Companies must differentiate themselves through innovation and performance to gain a competitive edge.
• Economic Uncertainties: Economic fluctuations and uncertainties can impact funding for research and development in the IHC sector. These economic factors can affect market growth and investment.

The immunohistochemistry market is shaped by drivers such as technological advancements, increasing cancer incidence, and automation, while facing challenges like high development costs and regulatory compliance. Addressing these drivers and challenges is crucial for success and growth in the market.

List of Immunohistochemistry Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunohistochemistry companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunohistochemistry companies profiled in this report include-

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem

Immunohistochemistry by Segment

The study includes a forecast for the global immunohistochemistry market by product, application, end use industry, and region.

Immunohistochemistry Market by Product [Analysis by Value from 2019 to 2031]:

• Antibodies
• Reagents
• Equipment
• Kits

Immunohistochemistry Market by Application [Analysis by Value from 2019 to 2031]:

• Diagnostic Applications
• Research Applications
• Forensic Applications

Immunohistochemistry Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

Immunohistochemistry Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Immunohistochemistry Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major immunohistochemistry producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., significant advancements include the introduction of multiplex IHC assays that allow for simultaneous detection of multiple biomarkers. This development enhances diagnostic accuracy and research capabilities, particularly in oncology and neurology.
• China: China is focusing on improving the quality and cost-efficiency of IHC products. The country is seeing growth in domestic production of IHC reagents and antibodies, leading to increased availability and affordability of these tools for research and clinical applications.
• Germany: Germany is leading innovations in automated IHC staining systems, which enhance throughput and consistency in laboratories. These systems are becoming more sophisticated, incorporating artificial intelligence for better image analysis and data interpretation.
• India: India is witnessing increased adoption of IHC in diagnostic laboratories due to a rise in cancer cases. There is also a push towards developing localized IHC solutions to meet specific regional needs and improve healthcare accessibility.
• Japan: Japan is advancing in the development of high-resolution IHC imaging techniques. These techniques improve the detection and quantification of biomarkers, supporting more precise diagnostics and research in various disease areas.

Features of the Global Immunohistochemistry Market

Market Size Estimates: Immunohistochemistry market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Immunohistochemistry market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the immunohistochemistry market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the immunohistochemistry market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostic applications, research applications, and forensic applications), end use industry (hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunohistochemistry Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Immunohistochemistry Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Immunohistochemistry Market by Product
  • 3.3.1: Antibodies
  • 3.3.2: Reagents
  • 3.3.3: Equipment
  • 3.3.4: Kits
• 3.4: Global Immunohistochemistry Market by Application
  • 3.4.1: Diagnostic Applications
  • 3.4.2: Research Applications
  • 3.4.3: Forensic Applications
• 3.5: Global Immunohistochemistry Market by End Use Industry
  • 3.5.1: Hospitals & Diagnostic Laboratories
  • 3.5.2: Academic & Research Institutes
  • 3.5.3: Other end users

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Immunohistochemistry Market by Region
• 4.2: North American Immunohistochemistry Market
  • 4.2.1: North American Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.2.2: North American Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.3: European Immunohistochemistry Market
  • 4.3.1: European Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.3.2: European Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.4: APAC Immunohistochemistry Market
  • 4.4.1: APAC Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.4.2: APAC Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.5: ROW Immunohistochemistry Market
  • 4.5.1: ROW Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.5.2: ROW Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
  • 6.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
  • 6.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
• 6.2: Emerging Trends in the Global Immunohistochemistry Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Immunohistochemistry Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F.Hoffmann-LA-Roche
• 7.2: Danaher
• 7.3: Agilent Technologies
• 7.4: Merck KGAA
• 7.5: Bio-Rad Laboratories
• 7.6: Eagle Biosciences
• 7.7: Biocare Medical
• 7.8: Elabscience Biotechnology
• 7.9: Bio-Genex Laboratories
• 7.10: Diagnostic Biosystem
• 7.11: Histo-Line Laboratories